Neurology Research

It is our intent to promote clinical research in Louisiana.  If you are conducting a study and would like to recruit patients, please let us know so we can list the study and basic inclusion/exclusion criteria.

If you are interested in conducting research in your practice please review:

Welcome   to a new opportunity for physicians and patients who want to learn about or participate in research studies of neurological diseases. This service will help people quickly find actively recruiting research studies for which they may be eligible. It will give physicians the opportunity to perform NINDS research in their own office and will provide the latest updates and results from research studies.

The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Services, has created the NINDS Clinical Research Collaboration (CRC) to help people join research studies to develop new and better treatments, faster.

NINDS-CRC Website

 

Multiple Sclerosis Study

*Study closed

The MS Clinic in the LSUHSC Department of Neurology is participating in a study to test the safety and effectiveness of an investigational oral medication for MS.  Study participants must be between 18 and 55 years of age, have had a diagnosis of MS for at least 6 months, with a documented relapse in the last year and currently not taking any medication for their MS.  If you would like more information about this study, please e-mail the MS Clinic at msclinic@lsuhsc.edu.  Drs. Gutierrez, Lovera and Bagert staff MS Clinic on the 1st and 3rd Wednesday of every month at 2820 Napoleon Ave., Suite 700, New Orleans, LA and can answer your questions about this clinical medication study.  Study medication, study tests and study office visits will be covered by the study sponsor, Teva Pharmaceutical.

Lacosamide Monotherapy Trial for Partial Seizures

*Still recruiting

Schwarz Biosciences is sponsoring a multi-site clinical trial for persons 16 to 70 years with a diagnosis of partial seizures.  Persons who meet the study criteria and are willing to participate will receive either 300 mg per day or 400 mg per day of Lacosamide for up to 20 weeks with a potential option to enter an open-label trial.  Study visits and study medication costs will be covered by the Sponsor (Schwarz).  Persons interested in getting more detailed study information should e-mail the study coordinator for the LSU Epilepsy Center of Excellence in New Orleans at epicenter@lsuhsc.edu.  Please provide your name, e-mail address or telephone number and the study in which you are interested.

Monotherapy Study with Lyrica for Partial Seizures

*still recruiting

Pfizer is sponsoring a clinical trial at the LSUHSC Epilepsy Center in New Orleans where eligible candidates will be 18 years or older and experiencing partial epileptic seizures.  Those meeting the additional study criteria and willing to participate will receive one of two doses of the study drug for 20 weeks as treatment for their partial seizures. Study visits and study medication costs will be covered by the Sponsor. At the end of the study, there may be an option to extend treatment with the study drug for about 6 months.  Anyone interested in getting more detailed study information should e-mail the study coordinator at epicenter@lsuhsc.edu.  Please provide your name, e-mail address or telephone number and the study in which you are interested.

 

 

http://careers.aan.com/distrib/jobs/xml.cfm?code=
Neurology Career Center
RosmanSearch, Inc.

Location: Louisiana


Ochsner Health System

Location: Gretna, Louisiana


The NeuroMedical Center

Location: Louisiana


Ochsner Health System

Location: Gretna, Louisiana


Ochsner Health System

Location: New Orleans, Louisiana


The NeuroMedical Center

Location: Louisiana


View all Neurology Career Center Jobs >